Down 66%, Should You Buy the Dip in Rigetti Computing?

Rigetti generated just about $7.1 million in 2025 revenue while posting more than $216 million in GAAP net losses, and Q1 2026 revenue was only $4.4 million with operating losses still persisting. The stock remains highly speculative at a P/S multiple of 607, even after falling 66% from all-time highs, and the article highlights ongoing insider selling and roughly $100 million in annual cash burn. Despite a $570 million liquidity cushion and minimal debt, the piece argues the valuation remains unjustified without a meaningful commercial breakthrough.

Analysis

The key market issue is not whether quantum computing matters, but whether public-market investors are pricing a platform transition as if it were already a cash-generative monopoly. That mismatch tends to unwind in two phases: first, multiple compression as narrative fatigue sets in; second, a funding overhang as the market starts discounting future dilution against a business model that still needs years of proof. The balance sheet buys time, but it also enables management to keep selling the dream longer than fundamentals would otherwise allow, which can extend the short squeeze / re-rating cycle even as business quality remains poor.

The better second-order read is that the crowded long is the pure-play quantum basket, while the more durable beneficiaries sit upstream in compute, tools, and adjacent infrastructure. If quantum hardware spending eventually scales, suppliers with real revenue today will absorb the capital before any stand-alone issuer reaches material operating leverage. That makes the thematic winners more likely to be semis, cloud, and experimental infrastructure vendors than the names issuing the highest-beta press releases.

The immediate catalyst path is asymmetric to the downside over the next 1-3 quarters: any quarter with flat-to-down revenue, continued operating losses, or equity issuance will likely trigger another leg of de-rating. The main reversal risk is not an earnings beat; it is a credible commercialization milestone that shortens the market’s time horizon to cash flow. Until then, the stock remains a sentiment instrument, not an operating asset, so price can overshoot fundamentals both ways, but the burden of proof is decisively on the bulls.

Consensus is probably still underestimating how little revenue visibility the market can tolerate once growth investors rotate out of frontier-tech speculation. The move may not be fully over yet, but it is likely underpinned by reflexive positioning rather than improving intrinsic value. That argues for fading strength rather than buying weakness, while keeping an eye on whether the company uses its elevated valuation to raise capital opportunistically.

Key Decisions for Investors

• Maintain/establish a tactical short in RGTIW or RGTI on strength over the next 1-4 weeks; target the next sentiment-driven spike, with a stop above any sustained breakout tied to a confirmed commercialization announcement.
• Prefer a pair trade: short RGTI / long GOOGL or NVDA for 1-3 months, expressing the view that real quantum option value is more efficiently owned through scaled platforms with current cash flows.
• If you want defined risk, buy medium-dated RGTI put spreads 2-4 months out; structure for a 2-3x payoff if the market re-rates the name on another weak quarter or dilution risk.
• Do not chase post-selloff dips in the pure-play quantum basket until there is evidence of accelerating revenue and narrowing losses; the risk/reward remains unfavorable unless the company proves a step-function commercial win.
• Watch for any equity issuance or insider selling as a trigger to add to shorts; those are the highest-probability catalysts for renewed multiple compression.